Rachael A Hagan Email and Phone Number
Rachael A Hagan work email
- Valid
- Valid
- Valid
- Valid
Rachael A Hagan personal email
Rachael A Hagan phone numbers
Results-oriented healthcare technology executive that brings a deep knowledge of the intersection of business, science, medicine, and government to the commercialization process of innovative medical technologies that improve patient outcomes and increase healthcare efficiency. Proven expertise in strategic planning and project management across cross-functional teams. Collaborative leader with excellent communication and relationship-building skills. Creative problem-solver with a demonstrated ability to grasp complex technical concepts, analyze key issues and policy implications, develop operational strategies and communicate with critical stakeholders. Experienced in promoting emerging technologies and businesses to investors and a strong track record of identifying, planning, and implementing strategic partnerships.
-
President And CeoNephrodi Therapeutics, Inc. Jul 2017 - PresentSeattle, Washington, UsDeveloping strategic plan, securing financing for and managing all functions of a start-up biotechnology company focused on developing drugs to treat Nephrogenic Diabetes Insipidus (NDI), a disease where patients produce extremely large amounts of dilute urine resulting from an inability of the kidney to respond to vasopressin.
-
External Review BoardMidwest Biomedical Accelerator Consortium Jan 2020 - PresentThe ERB will be tasked with selecting and funding the most promising technologies that go through the MBArC funding process and address unmet medical needs for diseases of high burden on the US healthcare system with apparent commercial potential.
-
Executive Oversight CommitteeUniversity Of Calgary Early Cancer Detection Initiative (Ecdi) Nov 2017 - PresentWith the support of the Canary Foundation and the Charbonneau Cancer Institute, the Early Cancer Detection Initiative is seeking to build an early cancer detection research hub for the commercialization of promising products.
-
ConsultantPitch Coach And Business Development Advisor 2012 - PresentStrengthen success prospects for startup biotech companies by advising on fundraising pitches and approaches to securing angel investment.
-
Business Development AdviserBiocomx - C3I Oct 2014 - PresentThe BioComX - C3i program is designed to provide innovators with the specialized business framework and essential tools for successful translation of biomedical technologies from lab to market.
-
Business Advisory BoardZephyrx Llc May 2019 - Aug 2020ZephyRx makes video games for respiratory therapy generating as much as a 20X increase in patient compliance. Their app downloads to your cell phone or tablet and connects with their custom, handheld, breath-activated game controller.
-
Senior DirectorEmory University / Georgia Institute Of Technology Dec 2013 - Jul 2017Atlanta, Georgia , UsEngaged to restructure and restart the Coulter Translational Partnership Fund to insure sustainable success of the Coulter Foundations investment in the two Universities combined evergreen fund. Managed fund that provided $1.5M a year for investment. During the first year of funding, managed eight commercially viable medical technology development teams. Three products out-licensed within the first six months. Additional four funded as of 7/1/16. • Personally identified translational projects, contributed to development of translational fund applications, and plans for product commercialization.• Produced business success stories by connecting innovators with technical and business resources and by promoting projects to angel and venture capital communities.• Propelled innovation at Emory Medical School and Georgia Tech Department of Bioengineering by providing focused leadership to faculty and administration that are developing projects with clear unmet clinical need.• Spurred fund’s awareness nationwide by conducting outreach events, creating online and print marketing materials, producing annual reports, and publically speaking at conferences.• Set-up commercialization training program aimed at teaching researchers proper skills to design commercial grade technologies. -
Business DevelopmentOtonexus Medical Technologies Inc. Jun 2013 - Jun 2015Joined start-up company - Managed business development team for series A fund raising.
-
Senior LectureUniversity Of Washington, School Of Pharmacy Jul 2013 - Dec 2013Biomedical Regulatory Affairs Master Program
-
DirectorUniversity Of Washington 2007 - 2013DIRECTOR – Wallace H. Coulter Translational Partnership Fund (2009–2013)Drove an innovative translational research process at a leading US research university to champion development of commercially viable medical technologies. Served as the liaison to the Wallace H. Coulter Foundation and to fund directors of 15 university partners; managed $1M yearly fund. Fund produced 30 successful licenses and professionally funded start-up. Over six year tenure managed 47 commercially viable medical technology development teams. Personally identified translational projects, contributed to development of translational fund applications, and plans for product commercialization.• Produced business success stories by connecting innovators with technical and business resources and by promoting projects to angel and venture capital communities.• Propelled innovation at UW Medical School and the Department of Bioengineering by providing focused leadership to faculty and administration that are developing projects with clear clinical need.• Spurred fund’s awareness nationwide by conducting outreach events, creating online and print marketing materials, writing annual reports, and providing public speaking at conferences.MANAGER – Wallace H. Coulter Translational Partnership Fund (2007–2009)Retained to establish business discipline within an academic environment. Promoted a cultural and operational transformation to improve fund effectiveness and interdepartmental relationships. • Stepped-up to elicit peak performance from fund resources; instituted a venture capital approach to funding projects and added disciplined due diligence process to identify successful technologies.• Restored trusting relationships with the Coulter Foundation and university to foster collaboration toward fund goals.
Rachael A Hagan Skills
Rachael A Hagan Education Details
-
University Of WashingtonRegulatory Affairs - Pharmacy -
Kieser CollegeComputer Programming
-
University Of South AlabamaCriminology
Frequently Asked Questions about Rachael A Hagan
What company does Rachael A Hagan work for?
Rachael A Hagan works for Nephrodi Therapeutics, Inc.
What is Rachael A Hagan's role at the current company?
Rachael A Hagan's current role is President and CEO at NephroDI Therapeutics, Inc..
What is Rachael A Hagan's email address?
Rachael A Hagan's email address is rt****@****ton.edu
What is Rachael A Hagan's direct phone number?
Rachael A Hagan's direct phone number is +140489*****
What schools did Rachael A Hagan attend?
Rachael A Hagan attended University Of Washington, Kieser College, University Of South Alabama.
What skills is Rachael A Hagan known for?
Rachael A Hagan has skills like Project Management, People Skills, Business Development, Leadership, Lifesciences, Microsoft Office, New Business Development, Problem Solving, Strategic Planning, Visio, Visual Basic, Web Design.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial